U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301658) titled 'Efficacy and Safety of Revodiol Calming Cream(R) in Atopic Dermatitis.' on Nov. 27.
Brief Summary: A 56-day clinical study evaluated Revodiol Calming Cream on pediatric and adult participants with mild to moderate atopic-prone skin under dermatological supervision. The product was applied twice daily, and efficacy was assessed through dermatological scoring, instrumental measurements, and subjective questionnaires. Results aimed to show improvements in barrier function, hydration, skin texture, and reduction of erythema, dryness, and pruritus, with feedback on comfort and quality of life.
Study Start Date: Feb. 27, 2023
Study Type...